Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Donnarumma · SciRah

Researcher profile · Semantic Scholar

L. Donnarumma

Share profile

L. Donnarumma — researcher profile on SciRah

h-index: 11
Works: 45
Citations: 352

Most-cited papers

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network
L. Kondili, G. Gaeta, M. Brunetto, A. Di Leo +47 more
2017PLoS ONE80 citations Open access
Semantic Scholar
Sustained virological response: a milestone in the treatment of chronic hepatitis C.
F. Morisco, R. Granata, T. Stroffolini, M. Guarino +6 more
2013World Journal of Gastroenterology68 citations Open access
Semantic Scholar
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection
F. Morisco, F. Castiglione, A. Rispo, T. Stroffolini +17 more
2013Journal of Viral Hepatitis32 citations
Semantic Scholar
Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
A. Tursi, G. Mocci, L. Allegretta, G. Aragona +46 more
2022Inflammatory Bowel Diseases29 citations
Semantic Scholar
Dietary approach in the prevention and treatment of NAFLD.
N. Caporaso, F. Morisco, S. Camera, G. Graziani +2 more
2012Frontiers in Bioscience27 citations Open access
Semantic Scholar
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.
A. Tursi, G. Mocci, A. Cuomo, L. Allegretta +38 more
2021European Review for Medical and Pharmacological Sciences19 citations
Semantic Scholar
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
A. Tursi, G. Mocci, A. Cuomo, A. Ferronato +46 more
2022Journal of Gastrointestinal and Liver Diseases15 citations Open access
Semantic Scholar
Pregnancy after liver transplantation: a case series and review of the literature
F. Zullo, G. Saccone, L. Donnarumma, I. Marino +2 more
2019Journal of Maternal-Fetal & Neonatal Medicine15 citations
Semantic Scholar
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Antonio Tursi, G. Mocci, F. Scaldaferri, D. Napolitano +59 more
2024Expert Opinion on Biological Therapy11 citations
Semantic Scholar
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study
G. Mocci, A. Tursi, F. Scaldaferri, D. Napolitano +80 more
2024Journal of Clinical Medicine11 citations Open access
Semantic Scholar
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
G. Mocci, A. Tursi, G. Maconi, G. Cataletti +60 more
2023Expert Opinion on Biological Therapy11 citations
Semantic Scholar
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination.
F. Morisco, T. Stroffolini, F. Lombardo, M. Guarino +5 more
2017Digestive and Liver Disease11 citations
Semantic Scholar
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
M. Sabbatini, Ivana Capuano, S. Camera, L. Ferreri +4 more
2018BioMed Research International8 citations Open access
Semantic Scholar
Vitamin D levels and chronic hepatitis C
F. Morisco, A. Colao, M. Guarino, V. Lembo +11 more
20135 citations
Semantic Scholar
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
A. Tursi, G. Mocci, F. Costa, L. Ceccarelli +53 more
2025Intestinal Research3 citations Open access
Semantic Scholar
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy
A. Tursi, G. Mocci, L. Allegretta, G. Aragona +51 more
2021Expert Opinion on Biological Therapy3 citations
Semantic Scholar
The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study
A. Santonicola, G. Bilancio, F. Zingone, L. Donnarumma +2 more
2020Gastroenterology Research and Practice2 citations Open access
Semantic Scholar
VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen
V. D. di Maio, M. Aragri, C. Masetti, S. Paolucci +81 more
20201 citations
Semantic Scholar
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)
L. Kondili, A. Di Leo, A. Iannone, T. Santantonio +44 more
20171 citations
Semantic Scholar
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study
Antonio Tursi, A. Pasta, W. Elisei, B. Barberio +87 more
2026Advances in Therapy0 citations Open access
Semantic Scholar
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study
Antonio Tursi, G. Mocci, F. Scaldaferri, D. Napolitano +97 more
2026American Journal of Therapeutics0 citations Open access
Semantic Scholar
P544 Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study
G. Mocci, F. Scaldaferri, D. Pugliese, E. Savarino +35 more
2024Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
P505 Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn’s disease: results from “long vedo” italian multicenter study
G. Mocci, G. Maconi, F. Onidi, G. Cataletti +36 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY
G. Mocci, G. Maconi, G. Cataletti, B. Mantia +44 more
2023Digestive and Liver Disease0 citations
Semantic Scholar
P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study
G. Mocci, A. Cuomo, L. Allegretta, G. Aragona +36 more
20210 citations
Semantic Scholar
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience
V. D. di Maio, M. Aragri, C. Masetti, S. Paolucci +65 more
2019Digestive and Liver Disease0 citations
Semantic Scholar
THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience
V. D. di Maio, M. Aragri, C. Masetti, S. Paolucci +54 more
2019Journal of Hepatology0 citations
Semantic Scholar
Optimization of direct antiviral agent treatment schedule in hepatitis C virus genotype 3 infection: an Italian, multicentetric experience in real-life setting
R. Granata, M. Valvano, L. Donnarumma, S. Camera +14 more
20170 citations
Semantic Scholar
Efficacy and safety of percutaneous laser ablation therapy for treatment of large HCC
S. Camera, G. D. Di Costanzo, R. Tortora, L. Addario +6 more
20160 citations
Semantic Scholar
Quantification of Serum HBsAg is a Useful Parameter to Optimize Antiviral NUC Therapy Schedule in Chronic Hepatitis B
M. Guarino, G. Portella, R. Bonavolta, F. Auriemma +5 more
20160 citations
Semantic Scholar
Efficacy and Safety of Percutaneous Laser Ablation Therapy for Treatment of Large Hepatocellular Carcinoma
S. Camera, G. D. Di Costanzo, R. Tortora, L. Addario +6 more
20160 citations
Semantic Scholar
P.17.7 REACTIVATION OF HBV INFECTION IN PATIENTS WITH LYMPHOMA TREATED WITH CHEMOTHERAPY CONTAINING OR NOT RITUXIMAB
F. Morisco, N. Pugliese, M. Guarino, M. Rea +10 more
20140 citations Open access
Semantic Scholar
HCV genotype 1a and 1b: Similarities and differences in clinical features, therapeutic outcome and predictors of response
F. Morisco, V. Di Marco, N. Caporaso, R. Granata +21 more
20140 citations
Semantic Scholar
P.17.8 CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTOR OF RESPONSE IN HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES
F. Morisco, V. Di Marco, N. Caporaso, R. Granata +22 more
20140 citations Open access
Semantic Scholar
P729 HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES IN CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTORS OF RESPONSE
F. Morisco, V. Di Marco, R. Granata, S. Camera +21 more
20140 citations
Semantic Scholar
Reactivation of hepatitis B virus in HBsAg-negative HBcAb-positive patients with psoriasis undergoing immunosuppressive therapy
F. Morisco, N. Balato, F. Ayala, M. Guarino +9 more
20140 citations
Semantic Scholar
Effect of immunosuppressive therapy with inflammatory bowel diseases and hepatitis B or C virus infection.
F. Morisco, F. Castiglione, A. Rispo, T. Stroffolini +17 more
20130 citations
Semantic Scholar
P.08.1 SURVIVAL OF PATIENTS WITH HCC IS IMPROVED BY SURVEILLANCE AND ADHERENCE TO SOC. A PROSPECTIVE STUDY IN A REFERRAL CENTRE
F. Morisco, M. Guarino, L. Donnarumma, I. Loperto +2 more
20120 citations
Semantic Scholar
P.08.2 SERUM LEVELS OF SCCA-IGM ARE RELATED TO THE EFFICACY OF HCC TREATMENTS
F. Morisco, M. Guarino, R. Tortora, L. Donnarumma +7 more
20120 citations
Semantic Scholar
P.15.10 IS THERE A DISTURBANCE OF VITAMIN D-PTH AXIS IN PATIENTS WITH NON CIRRHOTIC NON COLESTATIC CHRONIC HEPATITIS C? RESULTS FROM A CROSS-SECTIONAL STUDY
F. Morisco, M. Guarino, I. Loperto, L. Donnarumma +7 more
20120 citations
Semantic Scholar
T-19 Vitamin D–PTH axis in HCV infection
F. Morisco, M. Guarino, I. Loperto, L. Donnarumma +6 more
20120 citations
Semantic Scholar
OC.07.6 ITALIAN MULTICENTER STUDY ON INFLAMMATORY BOWEL DISEASES WITH HBV OR HCV INFECTION UNDERGOING IMMUNOSUPPRESSIVE THERAPY
F. Morisco, F. Castiglione, A. Rispo, T. Stroffolini +17 more
20120 citations
Semantic Scholar
P.08.23 CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA IN SOUTH ITALY
F. Morisco, M. Guarino, L. Donnarumma, I. Loperto +1 more
20120 citations
Semantic Scholar
OC.07.5 HCV-ANTIVIRAL THERAPY DELAYS GASTRIC EMPTYING TIME AND MODIFIES CCK AND MOTILIN SERUM LEVELS
G. de Nucci, A. Di Rocco, D. Compare, L. Donnarumma +5 more
20120 citations
Semantic Scholar
P.1.18: LONG-TERM HCV-ERADICATION. A 20 YEARS CLINICAL, VIROLOGICAL AND BIOCHEMICAL PROSPECTIVE STUDY
F. M. Orisco, R. Granata, S. Camera, L. Donnarumma +3 more
20110 citations
Semantic Scholar
456 LONG-TERM CLINICAL, BIOCHEMICAL AND VIROLOGICAL OUTCOMES AFTER SUCCESSFUL HCV-THERAPY
F. Morisco, T. Stroffolini, R. Granata, L. Donnarumma +2 more
20110 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Morisco×29
Invite
F. Morisco — researcher profile on SciRah
N. Caporaso×15
Invite
N. Caporaso — researcher profile on SciRah
S. Camera×14
Invite
S. Camera — researcher profile on SciRah
G. Mocci×14
Invite
G. Mocci — researcher profile on SciRah

×14

Invite

G. Forti — researcher profile on SciRah

Invite

S. Rodino — researcher profile on SciRah

Invite

L. Sebkova — researcher profile on SciRah

L. Allegretta×13

Invite

L. Allegretta — researcher profile on SciRah

Invite

R. Colucci — researcher profile on SciRah

A. Ferronato×13

Invite

A. Ferronato — researcher profile on SciRah

Invite

F. Gaiani — researcher profile on SciRah

C. Zampaletta×13

Invite

C. Zampaletta — researcher profile on SciRah